Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01382082 · ClinicalTrials.gov registry record
Assessment of Cognitive Function in Breast Cancer and Lymphoma Patients Receiving Chemotherapy
A clinical trial, sponsored by University of Rochester NCORP Research Base.
- Active
- Registry status
- 1,432
- Enrollment target
NCT01382082 is a clinical trial that is active but no longer recruiting, run by University of Rochester NCORP Research Base. The registered enrollment target is 1,432 participants.
The verdict
NCT01382082 is active but no longer recruiting, sponsored by University of Rochester NCORP Research Base.
- ACTIVE NOT RECRUITING
- Registry status
- 1,432 participants
- Enrollment target
Study Summary
Cognitive impairments in cancer patients represent an important clinical problem. Studies to date estimating prevalence of difficulties in memory, executive function, and attention deficits have been limited by small sample sizes and many have lacked healthy control groups. More information is needed on promising biomarkers and allelic variants that may help to determine the etiology of impairment, identify those most vulnerable to impairment, and develop interventions for these difficulties. This is a longitudinal observational study of cognitive function in breast cancer and lymphoma patients receiving chemotherapy to better understand the prevalence of cognitive difficulties (i.e., problems with memory, executive function, and attention) in these populations.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,432 participants |
| Start Date | 2011-07-14 |
| Est. Completion | 2026-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01382082
The ClinicalTrials.gov registry entry for NCT01382082 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 1,432 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Rochester NCORP Research Base, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01382082 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01382082 about?
NCT01382082 is a clinical study titled "Assessment of Cognitive Function in Breast Cancer and Lymphoma Patients Receiving Chemotherapy". Cognitive impairments in cancer patients represent an important clinical problem. Studies to date estimating prevalence of difficulties in memory, executive function, and attention deficits have been limited by small sample sizes and many have lacked healthy control groups. More information is neede...
What is the current status of trial NCT01382082?
This trial is currently active not recruiting. The enrollment target is 1,432 participants. The study started on 2011-07-14. Estimated completion is 2026-12-31.
Who is sponsoring clinical trial NCT01382082?
This trial is sponsored by University of Rochester NCORP Research Base, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.